Author:
Kagy Matthew K.,Amonette Rex
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference5 articles.
1. 1. MacKenzie-Wood A, Kossard S, deLauney J. Safety and efficacy trial evaluation 5% imiquimod cream with once daily application. Sydney, Australia: Skin and Cancer Foundation.
2. A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod
3. Cytokine induction by the immunomodulators imiquimod and S-27609
4. 4. Suzuki H, Wang B, Amerio P, et al. Topical immune response modifier imiquimod induces migration of Langerhans cells. Poster abstract. 57th annual meeting of the American Academy of Dermatology, March 1999.
5. 5. Beutner KR, Geisse JK, Helman D, Ginkel AM, Owens ML, Fox TL. A pilot study evaluating imiquimod 5% cream vs. vehicle in the treatment of primary superficial or nodular basal cell carcinoma. Poster abstract. 57th annual meeting of the American Academy of Dermatology, March 1999.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Basal cell carcinoma: An updated review of pathogenesis and treatment options;Dermatologic Therapy;2022-04-12
2. Advances in non and minimal-invasive transcutaneous delivery of immunotherapy for cancer treatment;Biomedicine & Pharmacotherapy;2020-11
3. GORLIN SYNDROME;Cassidy and Allanson's Management of Genetic Syndromes;2020-10-30
4. Gorlin (Naevoid Basal Cell Carcinoma) Syndrome;Harper's Textbook of Pediatric Dermatology;2019-11-20
5. Gorlin Syndrome;Atlas of Genetic Diagnosis and Counseling;2017